美年健康 (002044.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(美年健康)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 2,811,920,332.582,309,837,889.512,095,573,428.402,782,173,412.352,828,981,272.141,570,016,204.651,351,677,331.84
 营业收入(元) 2,811,920,332.582,309,837,889.512,095,573,428.402,782,173,412.352,828,981,272.141,570,016,204.651,351,677,331.84
二、营业总成本(元) 2,467,011,342.012,131,457,514.482,232,685,341.692,667,690,929.372,408,728,715.641,828,135,674.421,852,452,151.47
 营业成本(元) 1,573,392,851.151,354,910,616.281,413,922,699.021,679,287,001.651,570,151,007.441,176,828,246.881,176,151,527.07
 研发费用(元) 15,102,859.7713,755,195.7712,756,472.6420,364,548.7613,196,632.549,123,295.9013,667,894.76
 营业税金及附加(元) 734,405.74-3,811.692,101,274.972,760,991.861,017,294.20443,918.35750,613.14
 销售费用(元) 597,433,455.61505,785,635.89548,750,375.19647,044,144.35562,059,386.26398,365,442.02405,785,805.28
 管理费用(元) 203,131,252.15187,031,484.09186,991,133.90252,427,440.66189,296,627.06173,784,304.64183,056,516.60
 财务费用(元) 77,216,517.5969,978,394.1468,163,385.9765,806,802.0973,007,768.1469,590,466.6373,039,794.62
  其中:利息费用(元) 77,732,845.7372,138,062.3469,353,746.0865,669,101.8671,900,133.1173,064,454.8773,706,645.93
  其中:利息收入(元) 2,446,294.673,847,221.654,164,703.282,638,990.491,945,463.265,937,320.903,510,594.14
 资产减值损失(元) -756,275.35--685,618.84-31,639,675.57-1,502,656.29-1,592,972.07-1,412,340.52
 信用减值损失(元) -32,641,715.4931,448,293.64-17,005,481.00-89,908,366.85-30,298,535.31-23,868,818.97-14,667,938.65
三、其他经营收益
 加:公允价值变动收益(元) -4,445,650.65-1,932,543.25-796.7222,689,277.21-5,610,717.77247,408.182,480,347.67
 加:投资收益(元) -2,118,775.342,665,268.37-8,822,289.80-15,815,787.1924,548,704.65-740,304.82-8,948,648.50
  其中:对联营企业和合营企业的投资收益(元) 707,765.14-1,634,328.05-18,669,738.86-17,933,197.2512,466,062.15-11,972,165.11-26,291,355.33
 资产处置收益(元) -671,936.93-519,808.76-1,970,846.85-2,874,127.01-1,766,422.75-1,270,064.61-2,248,937.92
 其他收益(元) 2,343,204.052,721,101.304,764,718.075,181,033.788,936,086.179,315,309.235,723,076.53
四、营业利润(元) 306,617,840.86212,762,686.33-160,832,228.432,114,837.35414,559,015.20-276,028,912.83-519,849,261.02
 加:营业外收入(元) 2,514,241.903,736,084.081,335,577.421,904,549.611,255,439.031,951,212.72566,743.10
 减:营业外支出(元) 5,835,022.074,805,677.003,522,462.6241,331,467.502,965,942.41309,614.623,692,571.97
五、利润总额(元) 303,297,060.69211,693,093.41-163,019,113.63-37,312,080.54412,848,511.82-274,387,314.73-522,975,089.89
 减:所得税费用(元) 48,335,649.29-5,473,854.64-922,567.6366,710,366.7179,134,037.66-39,939,475.82-55,012,419.84
六、净利润(元) 254,961,411.40217,166,948.05-162,096,546.00-104,022,447.25333,714,474.16-234,447,838.91-467,962,670.05
(一)按经营持续性分类
  持续经营净利润(元) 254,961,411.40217,166,948.05-162,096,546.00-104,022,447.25333,714,474.16-234,447,838.91-467,962,670.05
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 215,451,111.11177,342,677.97-167,198,010.95-144,541,336.53277,886,579.58-235,378,371.97-431,104,101.40
  少数股东损益(元) 39,510,300.2939,824,270.085,101,464.9540,518,889.2855,827,894.58930,533.06-36,858,568.65
 扣除非经常性损益后的净利润(元) 224,399,846.54179,408,844.13-176,017,536.17-144,180,854.00271,122,046.43-249,108,852.10-445,666,341.32
七、每股收益
 一、基本每股收益(元) 0.060.04-0.04-0.040.07-0.06-0.11
 二、稀释每股收益(元) 0.060.04-0.04-0.040.07-0.06-0.11
八、其他综合收益(元) -134,810.27668,322.75-182,802.34-4,241,453.754,731,854.93691,315.54-55,976.22
 归属于母公司股东的其他综合收益(元) -96,317.49296,990.59-53,670.28-4,137,357.534,335,614.35330,841.42-10,317.82
 归属于少数股东的其他综合收益(元) -38,492.78371,332.16-129,132.06-104,096.22396,240.58360,474.12-45,658.40
九、综合收益总额(元) 254,826,601.13217,835,270.80-162,279,348.34-108,263,901.00338,446,329.09-233,756,523.37-468,018,646.27
 归属于母公司所有者的综合收益总额(元) 215,354,793.62177,639,668.56-167,251,681.23-148,678,694.06282,222,193.93-235,047,530.55-431,114,419.22
 归属于少数股东的综合收益总额(元) 39,471,807.5140,195,602.244,972,332.8940,414,793.0656,224,135.161,291,007.18-36,904,227.05
公告日期 2023-10-312023-08-302023-04-282023-04-252022-10-312022-08-312022-04-30
审计意见(境内) 标准无保留意见

前瞻产业研究院